CLINICAL ASTHMA
ASTHMA AND EXERCISE
Exercise is a common trigger for asthma symptoms , but asthma shouldn ’ t be a reason to avoid exercise .
|
Asthma is a common respiratory condition with attacks characterised by constriction of the bronchi and difficulty breathing . Reactions differ among individual cases , as do triggers , which include various allergens , psychological stress and exercise .
Exercise can be a trigger for asthma sufferers , but one of the goals of effective treatment of asthma is for sufferers to maintain a regular , healthy lifestyle , which includes exercise .
|
exercise , but certain activities are more likely to trigger asthma symptoms . These include sports performed in cold weather and endurance sports such as basketball or long-distance running . |
|
Patients should take these steps to ensure they exercise safely : 1 . Inhale through the nose and exhale through the mouth . Inhaling through |
the mouth while exercising is tough on the lungs . Breathing in through the nose means the air is moistened , warmed and filtered .
2 . Your doctor will be able to make adjustments to your medication to facilitate increased physical activity . Bronchodilators are usually recommended for use 15 minutes before exercise .
|
3 . Exercise indoors if pollution or pollen counts are high .
4 . Include warm-ups before and cooldowns after workouts .
5 . Never exercise when you ’ re not feeling well . 6 . Always carry an inhaler .
Reference Mediclinic Infohub
|
BENEFITS OF EXERCISE FOR ASTHMA
Avoiding triggers is a key component in managing and controlling asthma . But avoiding exercise can lead to sufferers becoming unfit and more vulnerable to attacks . The Cochrane Database of Systematic Reviews published a review of 19 studies on exercising with asthma in 2012 , which found that exercise for asthma sufferers is safe . The review also found that exercise improves heart and lung fitness and enhances quality of life . Other benefits of exercising with asthma include :
• Reduced symptoms
• Improved breathing
• Decreased stress and anxiety .
Most people with asthma should be able to exercise , provided their asthma is well controlled . They should be properly diagnosed and have a customised treatment plan to monitor and manage symptoms .
The most effective treatment of asthma is identifying and avoiding triggers . If exercise causes asthma symptoms , however , it is possible that a small change in the treatment plan is all that is needed for relief of symptoms during physical activity .
SAFETY FIRST Asthma causes the lungs to be hypersensitive to temperature , humidity , allergens and pollution .
Assess what level of activity would be appropriate , as well as which physical activity to choose . Swimming is a popular option for asthmatics , but there are a number of other activities to choose from .
Recommended physical activities for people with asthma :
• Swimming
• Yoga
• Pilates
• Walking
• Hiking
• Cycling
• Golf .
THAT CONFIDENT
FEELING
The Symbicord ® Turbuhaler ® offering confidence through experience 1
Years
Been studied in
57 global trials 1
More than
47 million patients treatment years around the world 1
S4 Symbicord ® Turbuhaler ® 80:4,5 μg / dose ( Inhaler ). Reg . No : 35 / 21.5.1 / 0404 . S4 Symbicord ® Turbuhaler ® 160:4,5 μg / dose ( Inhaler ). Reg . No : 35 / 21.5.1 / 0405 . Each delivered dose contains Budesonide 80 / 160 micrograms and formoterol fumarate dihydrate 4,5 micrograms . PHARMACOLOGICAL CLASSIFICATION : A 21.5.1 Corticosteroids and analogues . INDICATIONS : Asthma : SYMBICORD ® TURBUHALER ® 80:4,5 and 160:4,5 μg / dose is indicated in the treatment of asthma in adolescents and adults where use of a combination ( inhaled corticosteroid and long-acting beta-2-agonist ) is appropriate . COPD : SYMBICORD ® TURBUHALER ® 160:4,5 is indicated in the regular treatment of patients with moderate to severe chronic obstructive pulmonary disease ( COPD ), with frequent symptoms and a history of exacerbations . Symbicord ® and Turbuhaler ® are registered trademarks of the AstraZeneca group of companies . For full prescribing information refer to the package insert approved by the medicines regulatory authority .
S4 Symbicord ® Turbuhaler ® 320:9 μg / dose ( Inhaler ). Reg . No : 38 / 21.5.1 / 0187 . Each delivered dose contains Budesonide 320 micrograms and formoterol fumarate dihydrate 9 micrograms . PHARMACOLOGICAL CLASSIFICATION : A 21.5.1 Corticosteroids and analogues . INDICATIONS : Asthma : SYMBICORD ® TURBUHALER ® 320:9 μg / dose is indicated in the treatment of asthma in adolescents and adults needing inhaled corticosteroids where continued use of a high dose combination ( inhaled corticosteroid and long-acting beta-2-agonist ) is appropriate . COPD : SYMBICORD ® TURBUHALER ® 320:9 μg / dose is indicated in the regular treatment of patients with moderate to severe chronic obstructive pulmonary disease ( COPD ), with frequent symptoms and a history of exacerbations . Symbicord ® Turbuhaler ® are registered trademarks of the AstraZeneca group of companies . For full prescribing information refer to the package insert approved by the medicines regulatory authority .
Refrences : 1 . AstraZeneca data on file . December 2016 .
AstraZeneca Pharmaceuticals ( Pty ) Ltd . Reg . No . 1992 / 005854 / 07 . Building 2 , Northdowns Office Park , 17 Georgian Crescent West , Bryanston , 2191 , South Africa . Private Bag X23 , Bryanston , 2021 . Tel : 011 797-6000 . Fax : 011 797-6001 . www . astrazeneca . co . za . Expiry date : April 2019 . Activity ID : 830069
With proper guidance , it should be possible to undertake any form of
MEDICAL CHRONICLE | MAY 2017 39